Trial · NCT00330759
Adverse events1,182
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,182
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 264 | 878 | |
| other | Anaemia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 234 | 878 | |
| other | Leukopenia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 68 | 878 | |
| other | Leukopenia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 50 | 878 | |
| other | Neutropenia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 100 | 878 | |
| other | Neutropenia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 90 | 878 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Zoledronic Acid 4 mg Q4W | 86 | 878 | |
| other | Thrombocytopenia | Blood and lymphatic system disorders | Denosumab 120 mg Q4W | 90 | 878 | |
| other | Abdominal pain | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 86 | 878 | |
| other | Abdominal pain | Gastrointestinal disorders | Denosumab 120 mg Q4W | 84 | 878 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 38 | 878 | |
| other | Abdominal pain upper | Gastrointestinal disorders | Denosumab 120 mg Q4W | 47 | 878 | |
| other | Constipation | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 209 | 878 | |
| other | Constipation | Gastrointestinal disorders | Denosumab 120 mg Q4W | 188 | 878 | |
| other | Diarrhoea | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 165 | 878 | |
| other | Diarrhoea | Gastrointestinal disorders | Denosumab 120 mg Q4W | 163 | 878 | |
| other | Nausea | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 260 | 878 | |
| other | Nausea | Gastrointestinal disorders | Denosumab 120 mg Q4W | 244 | 878 | |
| other | Vomiting | Gastrointestinal disorders | Zoledronic Acid 4 mg Q4W | 167 | 878 | |
| other | Vomiting | Gastrointestinal disorders | Denosumab 120 mg Q4W | 174 | 878 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00330759/events